Pseudocannabinoid, H4CBD, Enhances Lipid Catabolism to Reduce Visceral Adiposity and Large Adipocyte Size in Advanced Metabolic Syndrome. // The Journal of Pharmacology and Experimental Therapeutics. – URL: https://www.sciencedirect.com/science/article/pii/S0022356526012711?dgcid=rss_sd_all
Pseudocannabinoid, H4CBD, Enhances Lipid Catabolism to Reduce Visceral Adiposity and Large Adipocyte Size in Advanced Metabolic Syndrome. The Journal of Pharmacology and Experimental Therapeutics. https://www.sciencedirect.com/science/article/pii/S0022356526012711?dgcid=rss_sd_all
“Pseudocannabinoid, H4CBD, Enhances Lipid Catabolism to Reduce Visceral Adiposity and Large Adipocyte Size in Advanced Metabolic Syndrome.” The Journal of Pharmacology and Experimental Therapeutics.
@article{article32393,
title = {Pseudocannabinoid, H4CBD, Enhances Lipid Catabolism to Reduce Visceral Adiposity and Large Adipocyte Size in Advanced Metabolic Syndrome},
journal = {The Journal of Pharmacology and Experimental Therapeutics},
url = {https://www.sciencedirect.com/science/article/pii/S0022356526012711?dgcid=rss_sd_all}
}